Information for Attendees

The Milner Therapeutics Symposium 2022 was our first hybrid symposium.
The in-person event was held at West Road Concert Hall in Cambridge, and sessions were also live-streamed to an online platform.

Themes

Oncology   ·   CNS therapeutics   ·   Infectious Disease  ·   Emerging technologies   ·   Disease-relevant models in target discovery

Speakers

Simon Boulton (Artios Pharma and The Francis Crick Institute), Lori Passmore (MRC Laboratory of Molecular Biology), Ravindra Gupta (Cambridge Institute of Therapeutic Immunology and Infectious Disease), Kristian Helin (Institute of Cancer Research), Giulia Biffi (CRUK Cambridge Institute, University of Cambridge), Matthias Zilbauer (Department of Paediatrics, University of Cambridge), Richard Hargreaves (Bristol Myers Squibb) and Andras Lakatos (Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge)

You can find out more about our speakers further down this page.

Panel Session

Shaping the future of interdisciplinary interactions

Chaired by Kristin-Anne Rutter (Cambridge University Health Partners)
Michael Anstey (Cambridge Innovation Capital) – Jamie Blundell (Institute for the Early Detection of Cancer, University of Cambridge) – Victoria Higgins (GlaxoSmithKline) –  Andy Neely (University of Cambridge) – Jeroen Verheyen (Semarion)

You can find out more about the panel session further down this page.

Posters

Posters from both academia and industry were presented in person and/or digitally as part of our hybrid Symposium. Selected posters are available for viewing on the online Symposium platform.